Synthesis method of Gabitril and its racemate and S-configuration
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI INST OF ORGANIC CHEM CHINESE ACAD OF SCI
- Publication Date
- 2006-12-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention provides a new synthesis method of Tiagabine, a medicine for treating epilepsy and GABA (γ-Aminobutyric acid) intake-related diseases. The invention also provides the preparation method of racemic tiagabine and S-configuration tiagabine. The invention also provides a preparation method of the optically pure ethyl β-piperidinecarboxylate, which is the raw material needed for synthesizing the above compound. Background technique
[0002]
[0003] In 1991, Nielsen et al. first reported that tiagabine (Tiagabine) had a good antispasmodic effect, and was also a good inhibitor of GABA (γ-Aminobutyric acid) uptake (Eur.J.pharmacol., 1991, 196 (3) , 257-266). At present, it has been developed as a drug for treating epilepsy and GABA (γ-Aminobutyric acid) intake-related diseases (CN 1225094A, 1999, 8, 4). Knud was equal to 1993 and reported its synthetic method (J.Med.Chem., 1993,36,1716-1725), but the two synthetic methods that they used ha...